"I have been lurking on these boards for a while, but I have to jump in to agree with you. It's important to remember that SR-aGVHD represents a relatively modest prospective market"
In monetary terms, yes. But dont undersell the incredible importance of last nights positive vote, and the probable/possible FDA approval to come. This result will really underpin everything MSB does from now on. IMO it is huge, and the market has very little idea of how to value it in the share price. It goes way beyond the sum-of-its-parts IMO.
As Dr. Arnold Caplan, the so-called “Father of MSCs” said in his impassioned plea to the Adcomm last night ... Approval of MSB's Remestemcel-L will be a "Watershed moment"
(20min delay)